These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases. Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287 [TBL] [Abstract][Full Text] [Related]
4. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies. Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564 [TBL] [Abstract][Full Text] [Related]
5. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives. Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967 [TBL] [Abstract][Full Text] [Related]
6. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group. Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
8. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies. Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519 [TBL] [Abstract][Full Text] [Related]
9. Investigation of potent inhibitors of cholinesterase based on thiourea and pyrazoline derivatives: Synthesis, inhibition assay and molecular modeling studies. Mumtaz A; Majeed A; Zaib S; Ur Rahman S; Hameed S; Saeed A; Rafique H; Mughal E; Maalik A; Hussain I; Iqbal J Bioorg Chem; 2019 Sep; 90():103036. PubMed ID: 31271943 [TBL] [Abstract][Full Text] [Related]
10. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002 [TBL] [Abstract][Full Text] [Related]
11. A New Class of Benzo[ Delogu GL; Begala M; Matos MJ; Crucitti D; Sogos V; Era B; Fais A Molecules; 2024 Aug; 29(16):. PubMed ID: 39202830 [TBL] [Abstract][Full Text] [Related]
12. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies. Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185 [TBL] [Abstract][Full Text] [Related]
13. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease. Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495 [TBL] [Abstract][Full Text] [Related]
14. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase. Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651 [TBL] [Abstract][Full Text] [Related]
15. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease. Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors. Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279 [TBL] [Abstract][Full Text] [Related]
17. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700 [TBL] [Abstract][Full Text] [Related]
20. Monoamine Oxidase Inhibition and Molecular Modeling Studies of Piperidyl-thienyl and 2-Pyrazoline Derivatives of Chalcones. Zaib S; Farooq Rizvi SU; Aslam S; Ahmad M; Al-Rashida M; Iqbal J Med Chem; 2015; 11(5):497-505. PubMed ID: 25544115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]